(Q57904446)

English

A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis

article by Efstathios Kastritis et al published 18 April 2012 in Blood

Statements

A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis (English)
0 references
E. Terpos
0 references
M. Roussou
0 references
M. Gavriatopoulou
0 references
C. Pamboukas
0 references
I. Boletis
0 references
S. Marinaki
0 references
T. Apostolou
0 references
N. Nikitas
0 references
G. Gkortzolidis
0 references
E. Michalis
0 references
S. Delimpasi
0 references
18 April 2012
0 references
0 references
119
0 references
23
0 references
5384-5390
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit